(S)-1-tert-Butyl 2-methyl piperazine-1,2-dicarboxylate hydrochloride, 95.0%, 250mg

(1-Methyl-1H-imidazol-5-yl)methylamine, 95.0%, 5g

1,1-Difluoroacetylacetone, 97.0%, 1g

N-(Methoxymethyl)acrylamide (stabilized with MEHQ)>95.0%(GC)(T)500g

Murexid (CI 56085), ACS, for Complexometry, 5 g, glass packaging

N-(9-((2R,3R,4R,5R)-3-((tert-Butyldimethylsilyl)oxy)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-9H-purin-6-yl)benzamide, 5g

2-(2-Amino-phenoxy)-ethanol, 95.0%, 5g

2-methyl-5-oxo-2-pyrrolidinecarbonitrile, 95.0%, 1g

2-(Aminomethyl)-1H-benzo[d]imidazole-6-carboxylic acid dihydrochloride, 97%, 1g

11-Mercaptoundecyl 2-Bromo-2-methylpropanoate>95.0%(HPLC)(T)1g

Ethyl 2-amino-2-methylpropanoate hydrochloride, 95.0%, 25g

2-(2-furyl)alanine, 95.0%, 1g

2-Nitro-N-(piperidin-4-yl)benzenesulfonamide hydrochloride, 95.0%, 1g